Search results
Found 440 matches for
We are delighted to announce that the Radcliffe Department of Medicine has been awarded an Athena Swan Silver award.
Scientists reveal how new diabetes and obesity drugs work
19 August 2025
A team led by scientists at the University of Oxford and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie in Berlin has used fluorescent versions of next-generation diabetes and obesity drugs to reveal, for the first time, exactly which cells they target in the pancreas and brain.
RDM DM student awarded prestigious Ramsay Scholarship
7 August 2025
RDM Doctor of Medicine (DM) student Nicholas Clarke is one of 28 exceptional young people awarded the 2025 Ramsay Postgraduate Scholarship.
New study links cancer stage to strength of antitumoral immune response in HR+ breast cancer
29 July 2025
The latest study from researchers in the MRC Translational Immune Discovery Unit in the MRC Weatherall Institute of Molecular Medicine has been published in Cell Reports Medicine.
Immune cells show promise in treating hypertrophic cardiomyopathy
21 July 2025
A new study from scientists at the Radcliffe Department of Medicine and Harvard Medical School, and funded by the British Heart Foundation, has uncovered a potential new treatment for hypertrophic cardiomyopathy (HCM).
£1.3m MRC Partnership Grant to expand the use of innovative Hyperpolarised Magnetic Resonance Imaging
15 July 2025
The technology has the potential to revolutionise the detection and monitoring of disease
Making it Personal – Engaging the public through theatre
14 July 2025
Innovative public engagement project explores the intersection of cutting-edge science and the raw honesty of the stage.
Thelior Bio: rethinking gut health from the inside out
10 July 2025
A new spinout company, formed from research conducted at the MRC Translational Immune Discovery Unit, aims to develop a new class of therapies for patients with inflammatory bowel disease.
New tool allows researchers to track how mutations arise in tissues
3 July 2025
Researchers at the MRC Weatherall Institute of Molecular Medicine and the German Cancer Research Center (DKFZ) have developed a new method to analyse how our tissues evolve as we age.
Celebrating science, collaboration and excellence at WIMM Day 2025
1 July 2025
The MRC Weatherall Institute of Molecular Medicine (WIMM) community gathered for its flagship annual event, WIMM Day, on Tuesday 24 June. Held at the Saïd Business School, the day showcased the breadth and impact of research across the institute and celebrated achievements in mentorship, public engag…
RDM announces a further three Principal Investigators for 2025
26 June 2025
We are delighted to announce the designation of three new Principal Investigators (PIs).
New research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia
10 June 2025
RDM researchers have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.
Congratulations to our new Associate Professors
5 June 2025
RDM is delighted to announce that the title of Associate Professor has been conferred on four of our researchers.
New research will map the impact of sleep and circadian rhythm disruption on cardiometabolic disease
4 June 2025
In the UK more than 4.3 million people live with Type-2 Diabetes, and 2.4 million more are at increased risk of developing the disease. Type-2 Diabetes, obesity, hypertension, and fatty liver disease frequently cluster together in the same individuals. It is becoming clear that sleep and body clock problems ha…
Diabetes UK Early Career Investigator Award for Dr Thomas Hill
30 April 2025
Congratulations to Dr Thomas Hill who has received a Diabetes UK Early Career Investigator Award at the Diabetes UK Professional Conference.
Daniela Nasteska showcases diabetes research in new Oxford Sparks video
29 April 2025
RDM’s Dr Daniela Nasteska introduces the colourful world of diabetes research via a brand-new video produced by Oxford Sparks.
Technician Champion appointed in RDM
2 April 2025
Facility Manager Michalina Mazurczyk, based in the MRC Weatherall Institute of Molecular Medicine, has been appointed as Technician Champion for the second year.
EAS Young Investigator Fellowship for Michail Mavrogiannis
1 April 2025
Congratulations to Michail Mavrogiannis who has been awarded an EAS Young Investigator Fellowship.
Landmark study finds no benefit of routine use of cerebral embolic protection devices on TAVI stroke risk
31 March 2025
Researchers say the devices cannot be recommended for routine clinical use in the UK.
New study reveals details of key immune mechanism
25 March 2025
An international collaboration, initiated by the Jackson Group at the MRC Weatherall Institute of Molecular Medicine, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.
Ancient genomic linkage regulates red blood cell development
24 March 2025
A collaboration between the Drakesmith and Higgs Groups at the MRC Weatherall Institute of Molecular Medicine has identified an ancient connection between metabolic and transcriptional control of erythropoiesis.